Exelixis
EXEL
#1682
Rank
A$15.37 B
Marketcap
$53.83
Share price
-1.00%
Change (1 day)
63.72%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: A$15.37 Billion

As of November 2024 Exelixis has a market cap of A$15.37 Billion. This makes Exelixis the world's 1682th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Marketcap Change
2024A$15.37 B40.38%
2023A$10.95 B44.02%
2022A$7.60 B-4.7%
2021A$7.97 B-1.48%
2020A$8.09 B5.9%
2019A$7.64 B-8.67%
2018A$8.37 B-27.32%
2017A$11.52 B92.1%
2016A$5.99 B239.79%
2015A$1.76 B412.03%
2014A$0.34 B-72.82%
2013A$1.26 B56.99%
2012A$0.80 B29.04%
2011A$0.62 B-29.13%
2010A$0.88 B-0.23%
2009A$0.88 B17.84%
2008A$0.75 B-27.33%
2007A$1.03 B-5.66%
2006A$1.09 B2.06%
2005A$1.07 B16.63%
2004A$0.92 B36.15%
2003A$0.67 B-19.81%
2002A$0.84 B-53.88%
2001A$1.82 B49.59%
2000A$1.22 B

End of Day market cap according to different sources

On Nov 14th, 2024 the market cap of Exelixis was reported to be:

A$15.52 Billion
by Nasdaq info icon info icon
A$15.52 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
A$106.17 B 590.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$194.70 B 1,166.63%๐Ÿ‡ซ๐Ÿ‡ท France
A$376.90 B 2,351.89%๐Ÿ‡บ๐Ÿ‡ธ USA
A$178.38 B 1,060.47%๐Ÿ‡บ๐Ÿ‡ธ USA
A$233.92 B 1,421.75%๐Ÿ‡บ๐Ÿ‡ธ USA
A$573.81 B 3,632.82%๐Ÿ‡บ๐Ÿ‡ธ USA
A$217.92 B 1,317.66%๐Ÿ‡บ๐Ÿ‡ธ USA
A$33.89 M-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.80 B-94.74%๐Ÿ‡บ๐Ÿ‡ธ USA